Protein A Resin Market by Product (Bulk Resin, Lab-scale Columns), Source (Recombinant Protein A), Matrix Type (Agarose-Based Protein A), Application (Monoclonal Antibody Purification, FC-Fusion Protein Purification) & End User - Global Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key secondary sources
    • 2.1.1.2 Key data from secondary sources
    • 2.1.1.3 Objectives of secondary research
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key supply and demand-side participants
    • 2.1.2.3 Breakdown of primary interviews
    • 2.1.2.4 Objectives of primary research
    • 2.1.2.5 Key primary insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation
    • 2.2.1.2 Customer-based market estimation
    • 2.2.1.3 Primary interviews
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 GROWTH RATE ASSUMPTIONS
• 2.4 DATA TRIANGULATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PROTEIN A RESIN MARKET OVERVIEW
• 4.2 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY COUNTRY AND END USER
• 4.3 PROTEIN A RESIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Strong monoclonal antibody pipeline to drive demand
    • 5.2.1.2 Advent of continuous bioprocessing to drive adoption
    • 5.2.1.3 Increased utilization due to expansion of bispecific antibodies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High manufacturing cost and pricing pressure
    • 5.2.2.2 Issues associated with scaling up resin production
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising outsourcing to CDMOs
    • 5.2.3.2 Innovative therapeutic indications
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limited resin reusability and fouling concerns
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 RESEARCH & DEVELOPMENT
  • 5.5.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
  • 5.5.3 DISTRIBUTION AND MARKETING & SALES
  • 5.5.4 AFTER-SALES SERVICES
• 5.6 SUPPLY CHAIN ANALYSIS
  • 5.6.1 PROMINENT COMPANIES
  • 5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
  • 5.6.3 END USERS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT & FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Recombinant protein A ligand engineering
    • 5.9.1.2 Alkaline-stable ligand development
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Automated column packing systems
    • 5.9.2.2 In-line monitoring and PAT (process analytical technology) tools
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Continuous chromatography systems
    • 5.9.3.2 Affinity membrane technology
• 5.10 PATENT ANALYSIS
  • 5.10.1 INNOVATIONS AND PATENT REGISTRATIONS
• 5.11 TRADE ANALYSIS
  • 5.11.1 IMPORT DATA FOR HS CODE 3504
  • 5.11.2 EXPORT DATA FOR HS CODE 3504
• 5.12 KEY CONFERENCES & EVENTS, 2025-2026
• 5.13 CASE STUDY ANALYSIS
  • 5.13.1 CASE STUDY 1: STRATEGIC CAPACITY EXPANSION BY PUROLITE (ECOLAB) TO STRENGTHEN SUPPLY CHAIN RESILIENCE IN PROTEIN A RESIN BUSINESS
  • 5.13.2 CASE STUDY 2: PROCESS INNOVATION BY CYTIVA TO ENHANCE REUSE CYCLES IN PROTEIN A RESINS
  • 5.13.3 CASE STUDY 3: TOSOH'S SINGLE-USE STRATEGY TO TAP INTO GROWING DEMAND FOR FLEXIBLE BIOPROCESSING
• 5.14 REGULATORY ANALYSIS
  • 5.14.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14.2 REGULATORY FRAMEWORK
    • 5.14.2.1 North America
      • 5.14.2.1.1 US
      • 5.14.2.1.2 Canada
    • 5.14.2.2 Europe
      • 5.14.2.2.1 UK
      • 5.14.2.2.2 Germany
      • 5.14.2.2.3 France
      • 5.14.2.2.4 Italy
      • 5.14.2.2.5 Spain
    • 5.14.2.3 Asia Pacific
      • 5.14.2.3.1 Japan
      • 5.14.2.3.2 China
      • 5.14.2.3.3 India
      • 5.14.2.3.4 Australia
    • 5.14.2.4 Latin America
      • 5.14.2.4.1 Brazil
      • 5.14.2.4.2 Mexico
    • 5.14.2.5 Middle East & Africa
      • 5.14.2.5.1 UAE
      • 5.14.2.5.2 South Africa
• 5.15 PORTER'S FIVE FORCES ANALYSIS
  • 5.15.1 THREAT OF NEW ENTRANTS
  • 5.15.2 THREAT OF SUBSTITUTES
  • 5.15.3 BARGAINING POWER OF SUPPLIERS
  • 5.15.4 BARGAINING POWER OF BUYERS
  • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.16.2 BUYING CRITERIA
• 5.17 UNMET NEEDS
• 5.18 IMPACT OF 2025 US TARIFFS-PROTEIN A RESIN MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 KEY TARIFF RATES
  • 5.18.3 PRICE IMPACT ANALYSIS
  • 5.18.4 IMPACT ON COUNTRIES/REGIONS
    • 5.18.4.1 North America
      • 5.18.4.1.1 US
    • 5.18.4.2 Europe
    • 5.18.4.3 Asia Pacific
  • 5.18.5 IMPACT ON END-USE INDUSTRIES
• 5.19 IMPACT OF AI/GEN AI ON PROTEIN A RESIN MARKET
  • 5.19.1 MARKET POTENTIAL OF AI/GEN AI IN PROTEIN A RESIN APPLICATIONS
  • 5.19.2 AI USE CASES
  • 5.19.3 KEY COMPANIES IMPLEMENTING AI/GEN AI
  • 5.19.4 FUTURE OF AI/GEN AI IN PROTEIN A RESIN ECOSYSTEM

6 PROTEIN A RESIN MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 BULK RESINS
  • 6.2.1 BULK RESINS TO HOLD LARGEST MARKET SHARE
• 6.3 PREPACKED COLUMNS
  • 6.3.1 CONSISTENCY AND LOW CROSS-CONTAMINATION RISK TO SUPPORT ADOPTION
• 6.4 LAB-SCALE COLUMNS
  • 6.4.1 FLEXIBILITY, LOW SAMPLE CONSUMPTION, AND HIGH THROUGHPUT TO DRIVE USAGE
• 6.5 OTHER PRODUCTS

7 PROTEIN A RESIN MARKET, BY SOURCE

• 7.1 INTRODUCTION
• 7.2 RECOMBINANT PROTEIN A
  • 7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH
• 7.3 NATURAL PROTEIN A
  • 7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A TO RESTRICT NATURALLY SOURCED COUNTERPARTS

8 PROTEIN A RESIN MARKET, BY MATRIX TYPE

• 8.1 INTRODUCTION
• 8.2 AGAROSE-BASED PROTEIN A
  • 8.2.1 AGAROSE-BASED PROTEIN A TO DOMINATE MARKET
• 8.3 GLASS/SILICA-BASED PROTEIN A
  • 8.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT MARKET GROWTH
• 8.4 ORGANIC POLYMER-BASED PROTEIN A
  • 8.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH

9 PROTEIN A RESIN MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 MONOCLONAL ANTIBODY PURIFICATION
  • 9.2.1 GROWING DEMAND, RAPID EXPANSION OF APPLICATIONS, AND INCREASING APPROVALS TO ENSURE LARGEST SHARE
• 9.3 FC-FUSION PROTEIN PURIFICATION
  • 9.3.1 INNOVATION AND PATENTED PUBLICATIONS TO DRIVE MARKET
• 9.4 OTHER APPLICATIONS

10 PROTEIN A RESIN MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
  • 10.2.1 EXTENSIVE USE IN BIOLOGICAL DRUG PRODUCTION TO ENSURE STRONG DEMAND
• 10.3 CROS & CDMOS
  • 10.3.1 EXPANSION OF BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET GROWTH
• 10.4 ACADEMIC & RESEARCH INSTITUTES
  • 10.4.1 INCREASING R&D IN DRUG DISCOVERY TO DRIVE USE OF PROTEIN A RESINS
• 10.5 OTHER END USERS

11 PROTEIN A RESIN MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Expansion in biomanufacturing and domestic capacity to drive market
  • 11.2.3 CANADA
    • 11.2.3.1 Policy-led capacity build and CDMO growth to drive the market
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Increased capital expenditure from manufacturers to drive market
  • 11.3.3 UK
    • 11.3.3.1 Government policies and public-private partnerships to drive market
  • 11.3.4 FRANCE
    • 11.3.4.1 CDMO capacity expansion and public programs to drive market growth
  • 11.3.5 ITALY
    • 11.3.5.1 Increased Cap Ex from major end-user categories to grow the demand for protein A resin
  • 11.3.6 SPAIN
    • 11.3.6.1 Increased CDMO and CRO likely to grow demand for protein A resin
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 CDMO capacity expansions, policy backing, and CDMO investment to propel market
  • 11.4.3 CHINA
    • 11.4.3.1 Robust biopharmaceutical expansion to grow demand
  • 11.4.4 INDIA
    • 11.4.4.1 Growth of pharma and biotech industries to drive demand for protein A resins
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 Increasing demand for protein-based therapeutics to drive growth
  • 11.4.6 SOUTH KOREA
    • 11.4.6.1 Developments in biopharmaceutical sector to drive market growth
  • 11.4.7 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Biomanufacturing emphasis and public-private partnerships to catalyze demand
  • 11.5.3 MEXICO
    • 11.5.3.1 Supportive government initiatives to grow demand for protein A resin
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Favorable government policies to propel market growth
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEIN A RESIN MARKET
• 12.3 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.4.1 MARKET RANKING OF KEY PLAYERS, 2024
• 12.5 COMPANY VALUATION & FINANCIAL METRICS
• 12.6 BRAND/PRODUCT COMPARISON
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.7.1 STARS
  • 12.7.2 PERVASIVE PLAYERS
  • 12.7.3 EMERGING LEADERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Region footprint
    • 12.7.5.3 Product footprint
    • 12.7.5.4 Matrix type footprint
    • 12.7.5.5 Application footprint
    • 12.7.5.6 End-user footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of key startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES & APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 DANAHER
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches
      • 13.1.1.3.2 Deals
      • 13.1.1.3.3 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 THERMO FISHER SCIENTIFIC INC.
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
      • 13.1.2.3.2 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 AGILENT TECHNOLOGIES, INC.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Deals
      • 13.1.3.3.2 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 BIO-RAD LABORATORIES, INC
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
  • 13.1.5 MERCK KGAA
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Expansions
      • 13.1.5.3.2 Other developments
  • 13.1.6 REPLIGEN CORPORATION
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
    • 13.1.6.4 MnM view
      • 13.1.6.4.1 Right to win
      • 13.1.6.4.2 Strategic choices
      • 13.1.6.4.3 Weaknesses and competitive threats
  • 13.1.7 TOSOH BIOSCIENCE
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Expansions
  • 13.1.8 ECOLAB INC.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
      • 13.1.8.3.2 Deals
      • 13.1.8.3.3 Expansions
    • 13.1.8.4 MnM view
      • 13.1.8.4.1 Key strengths
      • 13.1.8.4.2 Strategic choices
      • 13.1.8.4.3 Weaknesses & competitive threats
  • 13.1.9 NOVASEP HOLDING
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
  • 13.1.10 AVANTOR, INC.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
  • 13.1.11 OROCHEM TECHNOLOGIES, INC.
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
  • 13.1.12 KANEKA CORPORATION
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
  • 13.1.13 JSR CORPORATION
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
  • 13.1.14 GENSCRIPT
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
• 13.2 OTHER PLAYERS
  • 13.2.1 BIO-WORKS
  • 13.2.2 GENO TECHNOLOGY, INC.
  • 13.2.3 PROMEGA CORPORATION
  • 13.2.4 SUZHOU NANOMICRO TECHNOLOGY CO., LTD.
  • 13.2.5 TRANSGEN BIOTECH CO., LTD
  • 13.2.6 RESYN BIOSCIENCES (PTY) LTD
  • 13.2.7 BIOTOOLOMICS LTD.
  • 13.2.8 CALIBRE SCIENTIFIC (PROTEIN ARK)
  • 13.2.9 SUNRESIN NEW MATERIALS CO., LTD.
  • 13.2.10 BEAVER

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

List of Tables

• TABLE 1 PROTEIN A RESIN MARKET: INCLUSIONS & EXCLUSIONS
• TABLE 2 PROTEIN A RESIN MARKET: STUDY ASSUMPTIONS
• TABLE 3 PROTEIN A RESIN MARKET: RISK ANALYSIS
• TABLE 4 PROTEIN A RESIN MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
• TABLE 5 KEY PARAMETERS IMPACTING PRICES FOR PROTEIN A RESIN
• TABLE 6 AVERAGE SELLING PRICE TREND OF PROTEIN A RESIN, BY KEY PLAYER, 2022-2024 (USD)
• TABLE 7 AVERAGE SELLING PRICE TREND OF PROTEIN A RESIN, BY REGION, 2022-2024 (USD)
• TABLE 8 PROTEIN A RESIN MARKET: ROLE IN ECOSYSTEM
• TABLE 9 PROTEIN A RESIN MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
• TABLE 10 IMPORT SCENARIO FOR HS CODE 3504, BY COUNTRY, 2020-2024 (USD THOUSAND)
• TABLE 11 EXPORT SCENARIO FOR HS CODE 3504, BY COUNTRY, 2020-2024 (USD THOUSAND)
• TABLE 12 PROTEIN A RESIN: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
• TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS
• TABLE 18 PROTEIN A RESIN MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 19 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PROTEIN A RESIN, BY PRODUCT
• TABLE 20 KEY BUYING CRITERIA OF PROTEIN A RESIN, BY END USER
• TABLE 21 PROTEIN A RESIN MARKET: UNMET NEEDS
• TABLE 22 US ADJUSTED RECIPROCAL TARIFF RATES, 2024
• TABLE 23 KEY COMPANIES IMPLEMENTING AI/GEN AI IN PROTEIN A RESIN MARKET
• TABLE 24 PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 25 PROTEIN A RESIN MARKET FOR BULK RESINS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 26 PROTEIN A RESIN MARKET FOR PREPACKED COLUMNS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 27 PROTEIN A RESIN MARKET FOR LAB-SCALE COLUMNS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 28 PROTEIN A RESIN MARKET FOR OTHER PRODUCTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 29 PROTEIN A RESIN MARKET, BY SOURCE, 2023-2030 (USD MILLION)
• TABLE 30 RECOMBINANT PROTEIN A MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 31 NATURAL PROTEIN A MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 32 PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2023-2030 (USD MILLION)
• TABLE 33 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 34 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 35 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 36 PROTEIN A RESIN MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 37 PROTEIN A RESIN MARKET FOR MAB PURIFICATION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 38 PROTEIN A RESIN MARKET FOR FC-FUSION PURIFICATION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 39 PROTEIN A RESIN MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 40 PROTEIN A RESIN MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 41 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 42 PROTEIN A RESIN MARKET FOR CROS & CDMOS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 43 PROTEIN A RESIN MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 44 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 45 PROTEIN A RESIN MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 46 NORTH AMERICA: KEY MACROINDICATORS
• TABLE 47 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 48 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 49 NORTH AMERICA: PROTEIN A RESIN MARKET, BY SOURCE, 2023-2030 (USD MILLION)
• TABLE 50 NORTH AMERICA: PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2023-2030 (USD MILLION)
• TABLE 51 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 52 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 53 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 54 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 55 EUROPE: KEY MACROINDICATORS
• TABLE 56 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 57 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 58 EUROPE: PROTEIN A RESIN MARKET, BY SOURCE, 2023-2030 (USD MILLION)
• TABLE 59 EUROPE: PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2023-2030 (USD MILLION)
• TABLE 60 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 61 EUROPE: PROTEIN A RESIN MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 62 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 63 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 64 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 65 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 66 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 67 REST OF EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 68 ASIA PACIFIC: KEY MACROINDICATORS
• TABLE 69 ASIA PACIFIC: PROTEIN A RESIN, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 70 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 71 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY SOURCE, 2023-2030 (USD MILLION)
• TABLE 72 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2023-2030 (USD MILLION)
• TABLE 73 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 74 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 75 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 76 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 77 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 78 AUSTRALIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 79 SOUTH KOREA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 80 REST OF ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 81 LATIN AMERICA: KEY MACROINDICATORS
• TABLE 82 LATIN AMERICA: PROTEIN A RESIN, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 83 LATIN AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 84 LATIN AMERICA: PROTEIN A RESIN MARKET, BY SOURCE, 2023-2030 (USD MILLION)
• TABLE 85 LATIN AMERICA: PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2023-2030 (USD MILLION)
• TABLE 86 LATIN AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 87 LATIN AMERICA: PROTEIN A RESIN MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 88 BRAZIL: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 89 MEXICO: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 90 REST OF LATIN AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 91 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
• TABLE 92 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 93 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 94 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY SOURCE, 2023-2030 (USD MILLION)
• TABLE 95 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2023-2030 (USD MILLION)
• TABLE 96 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 97 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 98 GCC COUNTRIES: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 99 REST OF MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 100 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEIN A RESIN MARKET, 2022-2025
• TABLE 101 PROTEIN A RESIN MARKET: DEGREE OF COMPETITION
• TABLE 102 PROTEIN A RESIN MARKET: REGION FOOTPRINT
• TABLE 103 PROTEIN A RESIN MARKET: PRODUCT FOOTPRINT
• TABLE 104 PROTEIN A RESIN MARKET: MATRIX TYPE FOOTPRINT
• TABLE 105 PROTEIN A RESIN MARKET: APPLICATION FOOTPRINT
• TABLE 106 PROTEIN A RESIN MARKET: END-USER FOOTPRINT
• TABLE 107 PROTEIN A RESIN MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 108 PROTEIN A RESIN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND REGION
• TABLE 109 PROTEIN A RESIN MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-JUNE 2025
• TABLE 110 PROTEIN A RESIN MARKET: DEALS, JANUARY 2022-JUNE 2025
• TABLE 111 PROTEIN A RESIN MARKET: EXPANSIONS, JANUARY 2021-JUNE 2025
• TABLE 112 DANAHER: COMPANY OVERVIEW
• TABLE 113 DANAHER: PRODUCTS OFFERED
• TABLE 114 DANAHER: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 115 DANAHER: DEALS, JANUARY 2022-JULY 2025
• TABLE 116 DANAHER: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 117 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• TABLE 118 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
• TABLE 119 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-JULY 2025
• TABLE 120 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 121 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
• TABLE 122 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
• TABLE 123 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022-JULY 2025
• TABLE 124 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 125 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
• TABLE 126 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
• TABLE 127 MERCK KGAA: COMPANY OVERVIEW
• TABLE 128 MERCK KGAA: PRODUCTS OFFERED
• TABLE 129 MERCK KGAA: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 130 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2022-JULY 2025
• TABLE 131 REPLIGEN CORPORATION: COMPANY OVERVIEW
• TABLE 132 REPLIGEN CORPORATION: PRODUCTS OFFERED
• TABLE 133 REPLIGEN CORPORATION: DEALS, JANUARY 2022-JULY 2025
• TABLE 134 TOSOH BIOSCIENCE: COMPANY OVERVIEW
• TABLE 135 TOSOH BIOSCIENCE: PRODUCTS OFFERED
• TABLE 136 TOSOH BIOSCIENCE: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 137 ECOLAB INC.: COMPANY OVERVIEW
• TABLE 138 ECOLAB INC.: PRODUCTS OFFERED
• TABLE 139 ECOLAB INC.: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
• TABLE 140 ECOLAB INC.: DEALS, JANUARY 2022-JULY 2025
• TABLE 141 ECOLAB INC.: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 142 NOVOSEP HOLDING: COMPANY OVERVIEW
• TABLE 143 NOVOSEP HOLDING: PRODUCTS OFFERED
• TABLE 144 AVANTOR, INC.: COMPANY OVERVIEW
• TABLE 145 AVANTOR, INC.: PRODUCTS OFFERED
• TABLE 146 OROCHEM TECHNOLOGIES, INC.: COMPANY OVERVIEW
• TABLE 147 OROCHEM TECHNOLOGIES, INC.: PRODUCTS OFFERED
• TABLE 148 KANEKA CORPORATION: COMPANY OVERVIEW
• TABLE 149 KANEKA CORPORATION: PRODUCTS OFFERED
• TABLE 150 JSR CORPORATION: COMPANY OVERVIEW
• TABLE 151 JSR CORPORATION: PRODUCTS OFFERED
• TABLE 152 GENSCRIPT: COMPANY OVERVIEW
• TABLE 153 GENSCRIPT: PRODUCTS OFFERED
• TABLE 154 BIO-WORKS: COMPANY OVERVIEW
• TABLE 155 GENO TECHNOLOGY, INC.: COMPANY OVERVIEW
• TABLE 156 PROMEGA CORPORATION: COMPANY OVERVIEW
• TABLE 157 SUZHOU NANOMICRO TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
• TABLE 158 TRANSGEN BIOTECH CO., LTD: COMPANY OVERVIEW
• TABLE 159 RESYN BIOSCIENCES (PTY) LTD: COMPANY OVERVIEW
• TABLE 160 BIOTOOLOMICS LTD.: COMPANY OVERVIEW
• TABLE 161 CALIBRE SCIENTIFIC (PROTEIN ARK): COMPANY OVERVIEW
• TABLE 162 SUNRESIN NEW MATERIALS CO., LTD.: COMPANY OVERVIEW
• TABLE 163 BEAVER: COMPANY OVERVIEW

List of Figures

• FIGURE 1 PROTEIN A RESIN MARKET SEGMENTATION & REGIONAL SCOPE
• FIGURE 2 PROTEIN A RESIN MARKET: RESEARCH DATA
• FIGURE 3 PROTEIN A RESIN MARKET: RESEARCH DESIGN
• FIGURE 4 PROTEIN A RESIN MARKET: KEY SECONDARY SOURCES
• FIGURE 5 PROTEIN A RESIN MARKET: KEY DATA FROM SECONDARY SOURCES
• FIGURE 6 PROTEIN A RESIN MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES)
• FIGURE 7 PROTEIN A RESIN MARKET: KEY SUPPLY AND DEMAND-SIDE PARTICIPANTS
• FIGURE 8 PROTEIN A RESIN MARKET: BREAKDOWN OF PRIMARY INTERVIEWS (BY COMPANY TYPE, DESIGNATION, AND REGION)
• FIGURE 9 PROTEIN A RESIN MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS
• FIGURE 10 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 11 PROTEIN A RESIN MARKET: COMPANY REVENUE ESTIMATION
• FIGURE 12 PROTEIN A RESIN MARKET: END-USER AND REVENUE-MAPPING-BASED MARKET SIZE ESTIMATION METHODOLOGY
• FIGURE 13 PROTEIN A RESIN MARKET: TOP-DOWN APPROACH
• FIGURE 14 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS
• FIGURE 15 PROTEIN A RESIN MARKET: DATA TRIANGULATION METHODOLOGY
• FIGURE 16 PROTEIN A RESIN MARKET SHARE, BY PRODUCT, 2025 VS. 2030
• FIGURE 17 PROTEIN A RESIN MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION)
• FIGURE 18 PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2025 VS. 2030 (USD MILLION)
• FIGURE 19 PROTEIN A RESIN MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
• FIGURE 20 PROTEIN A RESIN MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 21 PROTEIN A RESIN MARKET: GEOGRAPHIC SNAPSHOT (2024)
• FIGURE 22 RISING ADOPTION OF PREPACKED DISPOSABLE COLUMNS TO FUEL MARKET GROWTH
• FIGURE 23 CHINA AND JAPAN TO ACQUIRE MAJOR SHARES OF ASIA PACIFIC MARKET IN 2024
• FIGURE 24 CHINA TO REGISTER HIGHEST CAGR FROM 2025 TO 2030
• FIGURE 25 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 26 PROTEIN A RESIN MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• FIGURE 27 AVERAGE SELLING PRICE TREND OF PROTEIN A RESIN, BY KEY PLAYER, 2022-2024 (USD)
• FIGURE 28 AVERAGE SELLING PRICE TREND OF PROTEIN A RESIN, BY REGION, 2022-2024 (USD)
• FIGURE 29 PROTEIN A RESIN MARKET: VALUE CHAIN ANALYSIS
• FIGURE 30 PROTEIN A RESIN MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 31 PROTEIN A RESIN MARKET: ECOSYSTEM ANALYSIS
• FIGURE 32 PROTEIN A RESIN MARKET: FUNDING AND NUMBER OF DEALS, 2019-2023 (USD MILLION)
• FIGURE 33 NUMBER OF DEALS IN PROTEIN A RESIN MARKET, BY KEY PLAYER, 2019-2023
• FIGURE 34 VALUE OF DEALS IN PROTEIN A RESIN MARKET, BY KEY PLAYER, 2019-2023 (USD)
• FIGURE 35 PROTEIN A RESIN MARKET: TOP COMPANIES/APPLICANTS FOR PROTEIN A RESIN PATENTS AND NUMBER OF PATENTS GRANTED, 2015-2025
• FIGURE 36 PROTEIN A RESIN MARKET: IMPORT SCENARIO FOR HS CODE 3504, 2020-2024
• FIGURE 37 PROTEIN A RESIN MARKET: EXPORT SCENARIO FOR HS CODE 3504, 2020-2024
• FIGURE 38 PROTEIN A RESIN MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 39 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PROTEIN A RESIN, BY PRODUCT
• FIGURE 40 KEY BUYING CRITERIA OF PROTEIN A RESIN, BY END USER
• FIGURE 41 KEY AI USE CASES IN PROTEIN A RESIN MARKET
• FIGURE 42 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT (2024)
• FIGURE 43 ASIA PACIFIC: PROTEIN A RESIN MARKET SNAPSHOT (2024)
• FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN PROTEIN A RESIN MARKET, 2020-2024 (USD MILLION)
• FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PROTEIN A RESIN MARKET, 2024
• FIGURE 46 MARKET RANKING OF KEY PLAYERS IN PROTEIN A RESIN MARKET, 2024
• FIGURE 47 EV/EBITDA OF TOP THREE PLAYERS (2025)
• FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF TOP THREE PLAYERS (2025)
• FIGURE 49 PROTEIN A RESIN MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 50 PROTEIN A RESIN MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 51 PROTEIN A RESIN MARKET: COMPANY FOOTPRINT
• FIGURE 52 PROTEIN A RESIN MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 53 DANAHER: COMPANY SNAPSHOT
• FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
• FIGURE 55 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
• FIGURE 56 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
• FIGURE 57 MERCK KGAA: COMPANY SNAPSHOT (2024)
• FIGURE 58 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2024)
• FIGURE 59 TOSOH BIOSCIENCE: COMPANY SNAPSHOT (2024)
• FIGURE 60 ECOLAB INC.: COMPANY SNAPSHOT (2024)
• FIGURE 61 AVANTOR, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 62 KANEKA CORPORATION: COMPANY SNAPSHOT (2024)
• FIGURE 63 JSR CORPORATION: COMPANY SNAPSHOT (2024)
• FIGURE 64 GENSCRIPT: COMPANY SNAPSHOT (2024)